|
|
|||||||
 |
|
|
LinkBack | Thread Tools | Display Modes |
04-08-2010, 11:32 AM
|
|||
|
|||
Rosetta Genomics Now Processing Fine-Needle Aspirate Cell Block Samples For Lung Canc
Rosetta Genomics, Ltd. (NASDAQ:ROSG), a leading developer and provider of microRNA-based molecular diagnostics, announced today that starting April 1, 2010 physicians are able to send FNA cell block samples to Rosetta Genomics' CLIA-certified and CAP-accredited laboratory in Philadelphia for analysis using Rosetta's miRview squamous test. FNA is a less invasive method to obtain tumor cells ...
    
|
|
| Thread Tools | |
| Display Modes | |
|
|
Similar Threads
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Rosetta Genomics Unveils Two New Development-Stage Tests | cancerfr | Mesothelioma | 0 | 09-10-2010 03:47 AM |
| Genekor to Distribute Rosetta Genomics' Assays | cancerfr | Mesothelioma | 0 | 07-31-2010 04:35 PM |
| Rosetta Genomics Now Processing Fine-Needle Aspirate Cell Block Samples For Lung Canc | cancerfr | Mesothelioma | 0 | 04-07-2010 10:44 AM |
| Rosetta Genomics' Philadelphia lab commences FNA cell block sample analysis with miRv | cancerfr | Mesothelioma | 0 | 04-05-2010 11:30 PM |
| Rosetta Genomics Now Processing Fine-Needle Aspirate Cell Block Samples for Lung Canc | cancerfr | Mesothelioma | 0 | 04-05-2010 12:29 PM |
Linear Mode
